Heart Institute Biorepository for children with heart disease
Official title: Heart Institute BioRepository (HIBR) for Pediatric Heart Disease
Run by Children's Hospital Medical Center, Cincinnati · NCT07478354 · Data updated 2026-11-12
This project collects and stores blood, tissue, and other samples from people with pediatric heart disease so researchers can use them to learn more and develop new tests and treatments.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | January 27, 2012 |
| Main results expected | January 1, 2050 |
| Study ends | January 1, 2050 |
| Registry record updated | April 8, 2026 |
| Trial ID | NCT07478354 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Any fetus, child, or adult at risk of or diagnosed with pediatric heart disease or cardiovascular disease, including patients seen for surgery, catheterization, imaging, inpatient or outpatient Heart Institute encounters, and females carrying a fetus with suspected cardiac diagnosis, are eligible.
✕Probably not a fit
Individuals who cannot give consent because their legal guardian is unauthorized or families who choose palliative care during pregnancy are excluded and therefore unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Heart Institute Biorepository is a prospective and retrospective observational collection that acquires, processes, organizes, and stores biological samples from patients seen at the Heart Institute. Samples include whole blood for DNA, plasma, urine, saliva, cardiovascular tissue, and explanted non-human prosthetics or grafts, and may be collected at surgery, catheterization, clinic visits, delivery, or other clinical encounters. The repository performs limited laboratory processing such as DNA isolation, plasma separation, and B-lymphocyte transformation to create immortalized cell lines and preserve genomic material for future use. Stored specimens are governed for investigator-initiated, translational, clinical, and outcomes research to serve institutional and broader research needs.
Why it matters
Potential benefit: If successful, the biorepository could accelerate discovery of genetic causes, biomarkers, and new therapies for pediatric cardiovascular disease by providing high-quality samples for many studies.
How similar studies have gone: Biorepositories and pediatric tissue banks have a track record of enabling genetic and biomarker discoveries and supporting translational cardiovascular research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Any fetus, child or adult at risk of or diagnosed with Pediatric Heart Disease (PHD) or Cardiovascular Disease (CVD) * Any HI patient, including the following types of encounters: Surgery or Cardiac Catheterization or Advanced Imaging encounters, Inpatient, including Cardiology service, consultation patients and Fetal Delivery, and Outpatient, including all HI-associated clinics and consultation services * Any female carrying a fetus with a suspected cardiac diagnosis Exclusion Criteria * Legal guardian unauthorized to consent * Families who choose Palliative care during pregnancy
Where it's running
-
Children's Hospital Medical Center, Cincinnati
Cincinnati, Ohio, United States Recruiting
Study contacts
- Principal investigator: Jeffrey Alten — Children's Hospital Medical Center, Cincinnati
- Study coordinator: Jeffrey Alten, MD
- Email: HIBioRepository@cchmc.org
- Phone: 513-636-2871
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Colchicine to see if it reduces coronary artery inflammation in people with HIV
This study tests whether low-dose colchicine can lower inflammation in the coronary arteries of people with HIV who are at high heart-disease risk, compared with a placebo.
-
Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation
This trial tests the Laplace TTVR System to see if it safely and effectively treats adults with severe tricuspid regurgitation.
-
A lifetime registry and imaging database for people with heart, kidney, and metabolic conditions
This project will see if creating a long-term clinical and imaging database for adults with heart, kidney, or metabolic conditions can improve prediction of outcomes and guide care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.